Trial
NCT02015910
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Merck Sharp & Dohme LLC
Condition
Type II Diabetes
Intervention
Sitagliptin
Why stopped
Terminated by the sponsor due to slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-06